GI Therapies was established in Melbourne in 2012 to commercialise innovative technology the treat gastrointestinal motility disorders including chronic constipation, irritable bowel syndrome with constipation and gastroparesis.
The technology - transabdominal gastrointestinal stimulation - TAGS™ - delivers non-invasive interferential electrical stimulation to the abdomen. The initial product, Rhythm IC™, consists of a garment (belt) that houses an electrode array on the front and back of the abdomen and a stimulator unit.
The Company received CE Mark in December 2016 for the first indication. Extended clinical trials will commence later in 2017 with a view to submit a marketing submission to the US FDA within two years.
Once fitted and training provided by a health care professional, the product is used at home and is suitable for adults and children.